SCHEMBL31452409

SCHEMBL31452409

COc1cccc2c1C(=O)N[C@H]1[C@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)C[C@H]21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLL Q9UGP5 1/20 0.37
POLB P06746 3/20 0.36
HTR2A P28223 5/20 0.34
HTR2C P28335 5/20 0.34
HTR2B P41595 5/20 0.34
L3MBTL1 Q9Y468 4/20 0.34
KDM4E B2RXH2 4/20 0.34
HSD17B10 Q99714 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
RECQL P46063 2/20 0.34
MASP2 O00187 1/20 0.34
GAPDH P04406 1/20 0.34
HSPA1A P0DMV8 1/20 0.34
THRB P10828 1/20 0.34
HSPA8 P11142 1/20 0.34
JUND P17535 1/20 0.34
TNNI3 P19429 1/20 0.34
APEX1 P27695 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31452292 0.87 HTR2A (0.35) POLBHTR2AHTR2CHTR2B
SCHEMBL31452285 0.77 POLL (0.44) POLLPOLBHTR2AHTR2CHTR2B
SCHEMBL31452350 0.76 CYP1A1 (0.37) ALDH1A1GAACYP2D6CYP2C9CYP2C19
SCHEMBL31452279 0.73 KRAS (0.34) HSD17B10RECQLCYP3A4TSHRGABRA1
SCHEMBL19249656 0.67 POLL (0.51) POLLPOLBHTR2AHTR2CHTR2B
SCHEMBL11352016 0.65 KDM4E (0.47) POLLPOLBL3MBTL1KDM4EHSD17B10
SCHEMBL10673437 0.62 FABP7 (0.57) POLBHTR2AHTR2CHTR2BL3MBTL1
SCHEMBL10673441 0.62 FABP7 (0.57) POLBHTR2AHTR2CHTR2BL3MBTL1
SCHEMBL3833035 0.62 POLL (0.51) POLLHTR2AHTR2CHTR2BL3MBTL1
SCHEMBL11362493 0.61 POLL (0.42) POLLPOLBHTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066306-A1 COMPOUNDS FOR TREATING MICROBIAL INFECTIONS, METHODS OF MAKING AND USES THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2025-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066306-A1 COMPOUNDS FOR TREATING MICROBIAL INFECTIONS, METHODS OF MAKING AND USES THEREOF ATF4, ATF1, CGAS POLL 4023/4885POLB 902/4885HTR2A 3864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.